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Summary 
Herpesvirus Saimiri gene 13 (HVS13) exhibits 57% 
identity with the predicted sequence of a T cell-derlved 
molecule termed CTLAI. Recombinant HVS13 and 
CTLA8 stimulate transcriptional factor NF-KS actlvlty 
and interleukin-6 (IL-6) secretion in flbroblasts, and 
costimulate T cell proliferation. An HVSlZFc fusion 
protein was used to isolate a cDNA encodlng a novel 
receptor that also binds CTLAI. This receptor is unre- 
lated to previously Identified cytokine receptor fami- 
lies. A recombinant soluble receptor inhlblted T cell 
proliferation and IL-2 production Induced by PHA, con- 
canavalin A (conA), and anti-TM MAb. These! results 
define CTLA8 and HVS13 as novel cytokines that bind 
to a novel cytokine receptor. We propose to call these 
molecules IL-17, vIL-17, and IL-17R, respectively. 
Introduction 
Cytokines are soluble proteins with pleiotropic biological 
activities that mediate immune responses and inflamma- 
tory reactions. Cytokines typically exert their biological 
functions by binding to specific cell surface receptors, 
which, in turn, activate signal transduction pathways 
within the cell (Kishimoto et al., 1994). They control activa- 
tion, proliferation, differentiation, and maturation of a wide 
variety of cell types (reviewed by Arai et al., 1990; Paul 
and Seder, 1994). Viral infection often elicits the secretion 
of cytokines, and their diverse biological functions clearly 
contribute to host defense mechanisms. In addition to me- 
diating antiviral activities, cytokines can promote the repli- 
cation and spread of viruses such as human immunodefi- 
ciency virus (HIV) (Poli et al., 1990) and human T cell 
leukemia virus type 1 (HTLV-1) (Greene et al., 1989). 
Many animal viruses encode proteins that interfere with 
normal cytokine function. Viruses use these proteins as 
countermeasures to host restrictions on viral replication 
and spread (reviewed by Gooding, 1992; Pickup, 1994; 
Spriggs, 1994). For example, several poxviruses have 
been shown to encode soluble receptors for interleukin-1 
(IL-l)(Alcamiand Smith, 1992; Spriggset al., 1992), tumor 
necrosis factor (TNF) (Smith et al., 1991), interferon 
(IFN)-a and -p (Colamonici et al., 1995; Symons et al., 
1995), and IFNy (Upton et al., 1992). In vivo studies using 
mutant viruses in which single genes have been deleted 
showed that these viral cytokine receptors can function as 
antagonists of cytokine activity, binding to their respective 
ligands with high affinity and blocking the interaction of 
the cytokine with its cellular receptor. In contrast, some 
herpesviruses encode cytokine receptors that are mem- 
brane bound and appear to transduce cellular signals in 
response to engagement with their ligands (Ahuja and 
Murphy, 1993; Gao and Murphy, 1994; Schall et al., 1995). 
Viruses also modulate the cytokine network by encoding 
functional homologs of cytokine themselves. For example, 
Epstein-Barr virus (EBV), a B-lymphotropic herpesvirus, 
contains an open reading frame (ORF) termed BCRFl, 
which encodes a homolog of IL-l 0. This viral IL-1 0 shares 
many of the biological properties of human IL-1 0, including 
inhibition of monocyte activation and IFNy synthesis (Hsu 
et al., 1990). 
Herpesvirus saimiri (HVS), like EBV, is a member of 
thesubfamilyGammaherpesvirinae(Roizman, 1992). The 
y-herpesviruses are noted for their lymphotropism and 
host range restriction. HVS is a naturally occurring benign 
pathogen of squirrel monkeys but is highly oncogenic in 
many New World primates and induces a fulminant lym- 
phoproliferative syndrome (Fleckenstein and Desrosiers, 
1982). HVS is also capable of transforming both simian 
and human T cells to continuous growth in vitro (Biesinger 
et al., 1992). The entire nucleotide sequence of HVS has 
been determined and predicted to encode 78 putative 
ORFs, which include a complement-regulating homolog 
and a protein with homology to an IL-8 receptor (Albrecht 
et al., 1992; Nicholas et al., 1992). 
Rouvier et al. (1993) previously identified a rodent cDNA 
sequence, termed CTLAB, from a T cell hybridoma that 
was derived from the fusion of a mouse cytotoxic T cell 
clone and a rat T cell lymphoma. The predicted amino 
acid sequence of CTLAB was found to be 57% identical 
to Herpesvirus saimiri gene 13 (HVS13) (Albrecht et al., 
1992). The predicted amino acid sequences suggested 
that both molecules would have signal sequences and 
potential N-linked glycosylation sites. Interestingly, the 3’ 
untranslated region (UTR) of the CTLA8 mRNA contained 
nucleotide sequences associated with mRNA instability, 
which are often found in the 3’ UTRs of many cytokines, 
growth factors, and proto+ncogenes (Shaw and Kamen, 
1986). No function for CTLA8 or HVS13 was identified, 
nor was the exact origin of the CTLA8 molecule described. 
However, the fact that a gene sequence from a T-lympho- 
tropic virus had homology to a cDNA found in a T cell 
hybridoma suggested that HVS13 might be derived from 
the host and play an important role in the virus-host inter- 
action. 
In this paper, we report the expression and biological 
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characterization of both HVS13 and IL-17 (murine CTLAB 
[mCTLA8]), and the cloning of a novel surface receptor 
from mouse T cells that binds to both of these proteins. 
Results 
Expression of HVSW and IL-1 7 (mCTLA8) 
To determine whether HVS13 is expressed during HVS 
infection, HVS-infected owl monkey kidney (OMK) cells 
were metabolically radiolabeled and immunoprecipitated 
with an HVSl3-specific antiserum. Supernatant and ly- 
sates from HVS-infected cells contained four unique pro- 
teins with apparent molecular masses of 17, 20, 23, and 
28 kDa, which reacted with an HVSl3-specific antiserum 
(Figure 1A). These proteins were not present in mock- 
infected cells (Figure 1A). 
A set of similar-sized proteins was present in superna- 
tant and lysates from CVl/EBNA cells transfected with 
HVS13 DNA, but not in cells transfected with empty vector 
(Figure 1 B). In the presence of tunicamycin, which inhibits 
the addition of N-linked oligosaccharides to proteins, the 
20,23, and 28 kDa species disappeared, while the protein 
of approximately 17 kDa increased (Figure 1 B, lanes 2 
and 3, 5 and 8), suggesting that the 20, 23, and 28 kDa 
proteins contained N-linked glycans. The 17 kDa protein 
most likely represents the unmodified form of the protein, 
which is consistent with the predicted molecular mass, 
while the other three proteins likely reflect sequential us- 
age of the three potential N-glycosyl addition sites in 
HVS13. 
To identify the IL-17 (mCTLA8) gene product, CVl/ 
EBNA cells transiently transfected with IL-17 (mCTLA8) 
cDNA were metabolically labeled in the presence or ab- 
sence of tunicamycin and the supernatants were analyzed 
by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). 
The YS-labeled supernatant from IL-17 (mCTLA8) ex- 
pressing cells contained two unique proteins with molecu- 
lar masses of approximately 17 and 21 kDa (Figure lC, 
lane 3). In the presence of tunicamycin, the 21 kDa protein 
disappeared, leaving only a 17 kDa protein, suggesting 
that the one potential N-linked glycosylation site in IL-17 
(mCTLA8) is utilized (Figure lC, lane 4). 
Molecular Cloning of the IL-17 Receptor 
In an effort to identify a receptor for HVS13 and IL-17 
(mCTLAB), a chimeric protein, comprising a portion of the 
Fc region of human immunoglobulin Gl (IgGl) followed 
by amino acids 19-151 of HVS13 (HVS13.Fc), was con- 
structed. HVS13.Fc protein was expressed, affinity puri- 
fied, and used to identify potential cell sources for its re- 
ceptor by flow cytometry. HVSl3.Fc was found to bind 
specifically to the murine thymoma cell line EL4, while a 
control Fc fusion protein did not (Figures 2A and 28). An 
EL4 cDNA library in a mammalian expression vector was 
screened using a slide-binding autoradiographic method 
as described (Goodwin et al., 1993). Two cDNA clones 
(P15 and Rl 1) that specifically bound HVS13.Fc were iso- 
lated. 
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Figure 1. Expression and Processing of HVS13 and IL-17 (mCTLA6) 
(A) lmmunoprecipitation of HVS13 from HVSinfected cells. HVS- 
infected or mock-infected OMK cells were labeled with 300 f&i/ml 
(?5]methionine and cysteine for 16 hr at 37OC. Supernatants (lanes 
1-4) or cell lysates (lanes 6-6) were immunoprecipitated with either 
a preimmune serum (lanes 1,3,5, and 7) or an anti-HVS13 polyclonai 
serum (lanes 2,4,6, and 6) and analyzed by 6%-16% SDS-PAGE 
under reduced conditions. 
(6) lmmunoprecipitation of HVS13 from transfected cells. CVllEBNA 
cells transfected with either HVS13 (lanes 2, 3, 5, and 6) or empty 
vector (lanes 1 and 4) in the absence (lanes 1,2,4. and 5) or presence 
(lanes 3 and 6) of 20 @ml tunicamycin were labeled with 100 t&i/ 
ml [?S]methionine and cysteine for 3 hr at 37OC. Labeled cell superna- 
tants and lysates were harvested, immunoprecipitated and analyzed 
as described in (A). 
(C) Expression of IL-1 7 (mCTLA6) in transfected cells. CVlRBNA cells 
transfected with IL-17 (mCTLA6) DNA (lanes 3 and 4) or empty vector 
(lanes 1 and 2) in the presence (lanes 2 and 4) or absence (lanes 1 
and 3) of 20 &ml of tunicamycin were labeled as in (B) and the 
supernatants analyzed by 6%-16% SDS-PAGE. 
To determine whether these cDNAs encoded proteins 
that also bound mCTtA8, two primers based on the pub- 
lished sequence of IL-17 (CTLAB) (Rouvier et al., 1993) 
were used in a reverse transcriptase-polymerase chain 
reaction (RT-PCR) on EL4 RNA to generate a DNA frag- 
ment that would encode the mature portion of IL-17 
(mCTLA8) (amino acids 20-180). The amplified sequence 
showed only 92% nucleotide identity to the CTtA8 se- 
quence described by Rouvier et al. (1993). We subse- 
quently isolated and sequenced a mouse IL-17 (mCTLA8) 
genomic clone. The amplified PCR sequence completely 
matched the nuc!eotide.sequencederivedfrom this mouse 
genomic clone (data not shown). Further analysis by PCR, 
using mouse and rat genomic DNAs as templates, or RT- 
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Figure 2. Binding of HVS13.Fcand mCTLA8.FctoEL4CellsandCVlI 
EBNA Cells Transfected with IL-17R cDNA 
EL4 cells were analyzed with a control Fc ([A], thick line), HVS13Fc 
([B], thick line), or mCTLAE.Fc ([Cl, thick line) proteins. Cells stained 
with secondary reagents alone are shown in thin lines. CVlIEBNA 
cells transfected with cDNA clone P15 (G-l) or empty vector (D-F) 
were analyzed with a control Fc (D and G), HVS13.Fc (E and H), or 
mCTLAE.Fc (F and I) proteins. 
PCR, using mou8e and rat cell RNA8 as templates, 
strongly suggested that the CTLA8 described by Rouvier 
et al. (1993) was of rat origin and may have been derived 
from the rat lymphoma, rather than the mouse cytotoxic 
T lymphocyte clone as its name suggested. A mCTLAB.Fc 
was constructed by fusing amino acids 20-l 50 of mCTLA8 
to the Fc region of human IgGl and expressed and purified 
in the same way as HVSl3.Fc. Both HVS13.Fc and 
mCTLA8.Fc bound to CVl/EBNA cell8 transfected with 
the cloned P15 cDNA, but not to cells transfected with 
empty vector (Figure 2). Only the result from clone P15- 
transfected cells is shown. The binding of HVS13.Fc and 
mCTLAB.Fc with the other IL-17 receptor (IL-17R) cDNA 
(Rll) was essentially identical (data not shown). 
Structure of the IL-17R 
Sequencing of these cDNA clones revealed that they con- 
tained either a 3.3 kb (P15) or a 1.7 kb (Rl 1) insert derived 
from the same mRNA. Clone P15 contained a single ORF 
of 2592 bp with a 120 bp 5’ noncoding sequence and a 
573 bp 3’ noncoding sequence (Figure 3). The Rll clone 
is a partial clone containing nucleotides 57-l 784. The pre- 
dicted initiator methionine is preceded by a purine at the 
-3 position and a purine at the +4 position, making it opti- 
mal for translation initiation (Kozak, 1991). The ORF is 
predicted to encode a type I transmembrane protein of 
884 aa. Computer-assisted analysis predicts that this pro- 
tein has an N-terminal signal peptide with a cleavage site 
after alanine at amino acid 31. The signal peptide is fol- 
lowed by a291 aaextracellulardomain, a21 aatransmem- 
brane domain, and a 521 aa cytoplasmic tail (Figure 3). 
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Figure 3. Nucleotide Sequence of a cDNA Encoding the IL-17R 
The nucleotide and deduced amino acid sequences of a cDNA encod- 
ing the IL-17R are shown. The predicted signal peptide is underlined, 
the putative transmembrane region doubly underlined, and potential 
N-linked glycosylation sites are in italics and underlined. 
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There are eight potential N-linked glycosylation sites in 
the extracellular domain. The predicted molecular mass 
for this protein is 97.8 kDa, with an estimated isoelectric 
point of 4.85. A comparison of both nucleotide and amino 
acid sequence8 with the GenBank or European Molecular 
Biology Laboratory database8 revealed no significant ho- 
mology with known nucleotide and protein sequences. 
Cellular and Tissue Distributlon of IL-17R mRNA 
Poly (A)+ RNA derived from various murine cell lines or 
tissues was examined by Northern blot analysis using the 
IL-17R cDNA as a probe. The IL-1 7R probe hybridized to 
a single species of mRNA of approximately 3.7 kb in all 
tissue8 examined. Among these, strong hybridizing sig- 
nals were observed in spleen and kidney. Moderate sig- 
nals were observed in lung and liver, and weaker signals 
in brain, heart, skeletal muscle, and testes (Figure 4A). 
Similar-sized mRNAs were detected in the following cells 
and cell lines: fetal liver epithelial cells (Dll), fibroblast 
(3T3), rat intestinal epithelial cells (lEC8), splenic B cells, 
muscle cells (884) mast cell8 (H7), triple-negative thymus 
cells (CD3CD4CD8-) (TN), pre-B cells (7OZ/3), T cell thy- 
moma(EL4);andTcellclones7C2andD1O(Figure4B).All 
the cell lines tested were found to express IL-17R mRNA, 
suggesting a ubiquitous expression of IL-17R message. 
Biochemical Characterization of the IL-17R 
EL4 cells or CVllEBNA cells transfected with IL-17R 
cDNA were surface biotinylated and subsequently immu- 
noprecipitated using HVS13.Fc or mCTLAB.Fc. Both Fc 
fusion proteins precipitated a protein with a molecular 
mass of approximately 120 kDa from the CVllEBNA cells 
transfected with IL-17R cDNA but not from cells 
transfected with empty vector (Figure 4C, lane8 1 to 8). 
A similar-sized protein was precipitated by HVS13.Fc and 
mCTLAB.Fc proteins from EL4 cells (Figure 4C, lanes 8 
and 9). The molecular mass of the IL-17R expressed in 
EL4 cells and in tran8feCted CVl IEBNA cells is larger than 
that predicted from it8 amino acid sequence, suggesting 
that the N-linked glycosylation sites in the extracellular 
domain may be utilized. 
Mouse Chromosomal Localization and Fine 
Mapping of IL-17R Gene 
A panel of DNA samples from an interspecific cross that 
had been characterized for over 900 genetic markers 
throughout the genome was analyzed. The genetic mark- 
ers included in this map span between 50-80 CM on each 
mouse autosome and the X chromosome (Chr) (Saunders 
and Seldin, 1990; Watson et al., 1992). Initially, DNA from 
the two parental mice (C3HIHeJ-gM and [C3H/HeJ-@d x 
Mus spretus] Fl) were digested with various restriction 
endonucleases and hybridized with the IL-17R cDNA 
probe to determine restriction fragment length variants 
(RFLVs) to allow haplotype analyses. Informative Bgll 
RFLVs were detected: C3HIHeJ-@d, 10.0 kb; Mus 
spretus, 7.8 kb and 2.2 kb. In each of the backcross mice, 
either the C3HIHeJ-gld parental band or all three bands 
(both Mus spretus bands and a half-intensity C3H/HeJ- 
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Figure 4. Identification of IL-17R mRNA and Protein 
(A and B) Northern blot analysis of IL-1 7R mRNA. Poly (A)+ RNA from 
the indicated tissues (A) or from Dll, 3T3, lEC6, splenic B cells, 
884, H7, TN, 7OU3, EL4, 7C2, and DIO cells (B) were hybridized 
with radioactive anti-sense riboprobes as described in Experimental 
Procedures. 
(C) lmmunoprecipitation of IL-17R with HVS13.Fc and mCTlAB.Fc 
proteins. CVllEBNA cells transfected with empty vector (lanes l-3), 
or IL-17R cDNA (lanes 4-6) or EL4 cells (lanes 7-S) were surface 
biotinylated, and cell lysates were precipitated with 5 &ml of control 
Fc (lanes 1. 4. and 7) HVS13.Fc (lanes 2, 5, and 8) or mCTlA8.Fc 
proteins (lanes 3, 8, and 9) and protein A-sepharose and electropho 
resed under reducing conditions on 8%-16% SDS-PAGE. Proteins 
were blotted onto an ECL membrane and detected using the ECL 
system after staining with streptavidin-conjugated horseradish peroxi- 
dase. 
g/d band) were observed, indicating that a single locus 
was detected. 
Comparison of the haplotype distribution of the IL-17R 
RFLVs indicated that this gene cosegregated in 111 of 
the 114 meiotic events examined with the Rafl gene locus 
on mouse Chr 8. The best gene order (Bishop, 1985) f 
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SD (Green, 1961) is: (centromere) Rafl-2.6 CM f 1.5 CM 
- IL-l 7R (provisionalgenetic designation) - 2.5 CM f 1.5 
CM - Cd4. 
Expression of IL-17R and induction of NF-KB Activity 
by HVS13 and IL-17 (mCTLA6) in Fibrobiasts 
Murine 3T3 ceils were found to express IL-17R by flow 
cytometry (Figure 5A). We then tested whether engage- 
ment of the IL-17R by its ligands would activate the tran- 
scription factor, NF-KB. 3T3 cells were incubated with 
HVS13 or IL-17 (mCTLA6), and electrophoretic mobility 
shift assays were performed to determine NF-KB activity. 
Incubation of 3T3 cells with supernatants containing the 
unmodified form of HVS13 or IL-17 (mCTLA6) or with 
HVS13.Fc or mCTLA6.Fc fusion proteins for 30 min re- 
sulted in the induction of protein-DNA complexes (Figure 
58). The formation of the slowest migrating complex could 
be inhibited by addition of excess unlabeled NF-KB oiigo- 
nucleotides containing a wild-type, but not a mutant, 
NF-KB binding sequence (Figure 58). To ensure that the 
stimulatory effects were specific to HVS13, an HVS13- 
specific MAb was used to neutralize NF-KB induction. The 
HVS13 MAb completely inhibited HVSl3-induced NF-KB 
activation, while an &type-matched MAb had no effect 
(Figure 58). 
To determine the role of IL-17R in HVS18 and IL-17 
(mCTlA6)-induced NF-KB activation, 3T3 cells were prein- 
cubated with an IL-17Rspecific antiserum and then as- 
sayed for NF-KB activation by HVS13. Preincubation with 
the IL-1 7R antiserum dramatically decreased the NF-KB 
activity induced by HVSl3 as compared with cells preincu- 
bated with an irrelevant rat antiserum (Figure 5C). This 
result indicated that the engagement of the IL-17R by its 
ligands induced NF-KB activity. 
IL-6 induction by HVS13 and IL-17 (mCTLA6) 
IL-6 production was measured from fibroblasts cultured 
with HVSI 3 or IL-1 7 (mCTLA6) containing supernatant or 
the corresponding Fc fusion proteins. Cells were cultured 
for 24 hr and conditioned media from these cultures were 
harvested and assayed for production of IL-6 by enzyme- 
linked immunoabsorbent assay (ELISA). Both HVSl3 and 
IL-17 (mCTLA6) containing supernatants induced a 26 to 
25-fold increase of IL-6 secretion in 3T3 cells (Figure 5D), 
while a control supernatant did not. Moreover, the induc- 
tion of IL-6 by HVS13 containing supernatant could be 
specifically blocked by an HVSl3-specific MAb, but not by 
an isotype-matched irrelevant MAb (Figure 5D). Similarly, 
HVSl3.Fc and mCTLAB.Fc induced IL-6 secretion in 3T3 
cells in a dose-dependent manner, while a control Fc pro- 
tein had no effect. (Figure 5E). 
Proliferative Response of T Ceils to HVSl3 
and IL-17 (mCTLA6) 
To examine potential biological activity of HVS13 and IL-1 7 
(mCTLA6) on cells of lymphoid origin, HVS13 and IL-17 
(mCTLA6) were tested for their ability to stimulate the pro- 
liferation of mouse T cells. Purified mouse splenic T cells 
were cultured with suboptimal concentrations of a costim- 
t P 
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Figure 5. Activation of NF-KB Activity and IL-5 Induction by HVS13 
and IL-17 (mCTLA3) in Fibroblasts 
(A) Expression of IL-I 7R on mouse 3T3 cells. 3T3 cells were dislodged 
from tissue culture flasks and stained with HVSl3.Fc. mCTLAB.Fc, 
or a control Fc (thick lines) as described in Figure 2. Cells stained 
with secondary antibody only are shown in thin lines. 
(8) 3T3 cells were treated with a control supernatant, HVS13, or IL-17 
(mCTLA3) containing supernatant, 200 @ml of a control Fc, 
HVS13.Fc. or mCTLAB.Fc proteins for 30 min. Alternatively, HVSl3 
containing supernatant was preincubated with either a control MAb 
or an HVSl5specific MAb for 1 hr before adding to 3T3 cells. Nuclear 
extracts were prepared and, in some cases, reaction mixtures were 
supplemented with a lOWold excess of cold oligonucleotides con- 
taining either a wild-type or a mutated NF-KB binding site. 
(C) Inhibition of HVSlSinduced NF-KB activity by an anti-IL-17R se- 
rum. 3T3 cells were either treated with I:250 or 1 :I000 dilutions of 
an IL-17R antiserum or an irrelevant rat anti-serum for 1 hr. NF-KB 
assays were then performed as described in (B). 
(D and E) Induction of IL-6 secretion by HVS13 and IL-17 (mCTLA8). 
3T3 cell monolayers were cultured with the indicated stimuli (D) or a 
titration of HVSl3.Fc (open squares), mCTlAB.Fc (open triangles), 
control Fc (open circles), or media (open diamonds) for 24 hr (E). 
Conditioned media were collected and assayed for IL-5 by ELISA. 
ulus in the presence of titrated amounts of HVSl3.Fc or 
mCTLAB.Fc or supernatants containing the unmodified 
form of HVSl3 or IL-1 7 (mCTLA6). Proliferation was mea- 
sured after 3 days of culture. Both HVS13.Fc and 
mCTLA6.Fc (Figure 6A), as well as their non-Fc counter- 
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Figure 6. Proliferative Response of T Cells to HVS13 and IL-17 
(mCTLA8) 
Purified mouse splenic T cells (2 x 105/well) were cultured with 1% 
PHA and a titration of HVS13.Fc (closed triangles), mCTLAB.Fc (open 
squares), or control Fc (open circles) (A), or serial dilutions of HVS13 
(closed triangles), IL-17(mCTLAB)(opensquares)containing superna- 
tant, or a control supernatant (open circles) (6). Results are expressed 
as mean cpm * SEM. The cpm for unstimulated cells in (A) was 31; 
for cells stimulated with PHA, 1163. In (B), cpm for unstimulated cells 
was 44; for cells stimulated with PHA, 3073. 
parts (Figure 6B), enhanced the proliferative response of 
purified mouse splenic T cells 3-to 4-fold in the presence 
of suboptimal phytohemagglutinin(PHA). Neitheracontrol 
Fc protein nor supernatant had any effect on the mouse 
T cell proliferation (Figures 6A and 66). 
Biological Effect of Soluble IL-17R 
A soluble IL-1 7R.Fc fusion protein was constructed by fus- 
ing the extracellular domain (residues l-323) of IL-17R to 
the Fc portion of human immunoglobulin IgGl. The effect 
of the IL-17R.Fc fusion protein on the biological activity 
of IL-17 (mCTLA8) and HVS13 was examined in a system 
measuring IL-6 production. 3T3 cells were cultured with 
either IL-17 (mCTLA8) or HVS13 in the presence of either 
a soluble IL-1 7R.Fc or a control Fc protein for 24 hr and 
IL-6 production was measured by ELISA. When the cells 
were cultured with IL-17 (mCTLA8) (Figure 7A) or HVS13 
Figure 7. Biological Functions of Soluble IL-17R 
(A and B) Effect of soluble IL-17RFc protein on HVS13 and IL-17 
(mCTLA8) induced IL-6 secretion. 3T3 cells were cultured with 50 ng/ 
ml mCTtAS.Fc (A) or HVS13.Fc (6) in the presence of a titration of 
IL-17R.Fc (closed square) or a control Fc (open circle) for 24 hr. Condi- 
tioned media were collected and IL-6 measured by ELISA. 
(C, D, and E) Effect of soluble IL-1 7R.Fc protein on T cell proliferation 
induced by conA (C), PHA (D), and immobilized anti-TCR ap MAb (E). 
Murine T cells were cultured for 3 days with 1 ug/ml of conA or 2% 
PHA in the presence of various concentration of IL-17R.Fc (closed 
square) or a control Fc (open circle). Results are expressed as mean 
cpm of triplicate cultures f SEM. These are representative results 
of eight experiments performed. Alternatively, murine T cells were 
cultured for 3 days with 1 pg/ml of immobilized anti-TCR ab MAb or 
1 pglmlantiCD28MAborbothin thepresenceof20ug/mlIL-17R.Fcor 
a control Fc (E). These are representative results of three experiments 
performed. 
(F) Effect of soluble IL-1 7R.Fc on IL-2 production induced by mitogens. 
Murine T cells were cultured for 24 hr with 1 &ml of conA in the 
presence or absence of 10 pglml of IL-17R.Fc or in the presence of 
a control Fc. IL-2 production was measured by ELISA and results 
expressed as nglml IL-2 produced. These are representative results 
of three experiments performed. 
(Figure 78) the addition of increasing amountsof asoluble 
IL-17R.Fc resulted in increased inhibition of the HVSl3- 
and IL-17 (mCTLAB)-induced IL-6 production. In contrast, 
the control Fc protein had no effect on HVS18 and IL-17 
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(mCTLA8)-induced IL-8 secretion. These results demon- 
strate that the IL-17R.Fc is capable of specifically neu- 
tralizing the biological effects of HVS13 and IL-17 
(mCTLA8) in an in vitro assay. 
To determine whether endogenously produced IL-I 7 
(mCTfA8) plays a role in T cell proliferation, T cells were 
stimulated with conA or PHA or anti-TCR MAb in the pres- 
ence of either soluble IL-17RFc protein or a control Fc 
protein. IL-1 7RFc significantly inhibited T cell proliferation 
induced by conA, PHA, immobilized anti-TCR ab MAb, 
and anti-CD28 MAb compared with a control Fc protein 
(Figures 7C, 7D, and 7E). Analysis of IL-2 production by 
splenic T cells activated with conA in the presence or ab- 
sence of IL-17R.Fc in the culture revealed that addition 
of IL-17R.Fc to the T cell culture inhibited IL-2 production 
to levels 8 to O-fold lower than those observed in cultures 
containing media alone or media plus a control Fc protein 
(Figure 7F). 
Discuselon 
This paper describes the isolation of a novel murine cyto- 
kine receptor using a virus-encoded cytokine as a probe. 
Recombinant HVS13 and IL-17 (mCTLA8) exhibit classic 
pleiotropic activities: activation of NF-~6, induction of IL-8 
secretion in fibroblasts, and stimulation of T cells to prolif- 
erate in the presence of costimuli. These effects are medi- 
ated through the interaction between HVSl3 and IL-17 
(mCTlA8) and a specific cell surface receptor, IL-17R. 
IL-17R does not appear to be structurally related to any 
known cytokine receptor family. Despite the existence of 
12 cysteine residues in the extracellular domain, their rela- 
tive positions are not characteristic of receptors belonging 
to the immunoglobulin superfamily (Williams and Barclay, 
1988) or the TNF receptor family (Smith et al., 1990). The 
extracellular domain does not contain the WSXWS motif 
found in hematopoietin receptor family members (Cos- 
man, 1993). The cytoplasmic tail of the IL-17R is rather 
large in size (521 residues), and an examination of the 
amino acid sequence indicates no apparent homology 
with the catalytic domain of any other growth factor recep- 
tor known to be a tyrosine kinase (Hanks et al., 1988). 
There is a relatively large proportion of acidic (18% of 
aspartic acid and glutamic acid) and proline residues(9%), 
similar to that observed in other growth factor receptors 
(Alcover et al., 1987; Hatakeyama et al., 1989). Using a 
computer-assisted BLOCK search (Henikoff and Henikoff, 
1991; Wallace and Henikoff, 1992), a segment (TPPPLR- 
PRKVW) located proximal to the IL-17R transmembrane 
domain was found, which is highly conserved among cy- 
tokine receptors (Murakami et al., 1991). Furthermore, 
there are two acidic regions and a serine-rich region in 
the cytoplasmic domain of IL-17R, similar to that found in 
the IL-2R 8 chain (Hatakeyamaet al., 1989) lL4R (Mosley 
et al., 1989) and GCSFR (Fukunagaet at., 1990). Whether 
these regions have any significance in IL-17 signal trans- 
duction is under current investigation. 
The IL-17R has the ubiquitous tissue distribution seen 
with several other cytokine receptors including, TNF re- 
ceptor (Smith et al., 1990), IL-1 receptor (McMahan et al., 
1991) and the signal transduction subunit gp130 (Hibi et 
al., 1990). The wide expression of the receptor is in con- 
trast with the very restricted expression reported for 
CTLAI (Rouvier et al., 1993). Our RT-PCR experiments 
have indicated that IL-17 (mCTLA8) is expressed in both 
T cells activated by different stimuli and in EL4 cells (data 
not shown). 
The finding that HVS13 activates NF-KB activity is intri- 
guing. NF-KB is a transcription factor known to regulate 
a large number of gene products involved in cell activation 
and growth control. NF-KB-induced gene products include 
molecules involved in immune, inflammatory, or acute 
phase responses, such as immunoglobulin light chain, 
major histocompatibility complex (MHC), IL-2R a chain, 
and cytokines such as IL-18 IL-8 and TNFa (reviewed 
by Lenardo and Baltimore, 1989; Siebeniist et al., 1994). 
NF-KB directly stimulates the HIV enhancer in T cells and 
can itself be activated by different viral proteins with onco- 
genie potential, such as the hepatitis B virus HBX protein, 
EBV LMPI, and HTLV-1 Tax protein (Laherty et al., 1992; 
Lucite and Schneider, 1992; Hirai et al., 1994). The induc- 
tion of NF-KB by Tax results in up-regulation of IL-2 and 
IL-2R and subsequently uncontrolled T cell growth (Mc- 
Guire et al., 1993). These observations raise interesting 
questions concerning the role of HVS13 in the etiology of 
HVS-induced T cell malignancy. Primates, experimentally 
infected with HVS, die from rapidly progressing neoplasias 
of the immune system. It is possible that binding of HVSI 3 
to its receptor on the ceil surface activatessignal transduc- 
tion pathways that ultimately regulate specific transcrip- 
tion factors involved in oncogenesis. The mitogenic effect 
of HVS13 may stimulate neighboring uninfected cells into 
inappropriate proliferation. Alternatively, HVS13 interac- 
tion with its receptor may be part of the physiological cyto- 
kine network operating within these tumors. Consistent 
with this hypothesis is the finding that HVS13 is able to 
induce IL-8 secretion. IL-8 has been shown to be a potent 
growth factor for myeiomas, plasmacytomas, and hybrido- 
mas(Kawano et al., 1988; Kishimoto, 1989)and isinvolved 
in the growth of Lennert’s T lymphoma cells (Shimizu et 
al., 1988). 
The expression of a protein with cytokine activity may 
be advantageous to HVS during natural infection. HVSI 3 
secreted by HVS-infected cells may bind to neighboring 
uninfected cells bearing the IL-17R and stimulate their 
metabolism, enhance their differentiation, cause them to 
proliferate, or some combination of the three. Activated 
cells may serve as better targets for infection or more effi- 
ciently support virus replication. Human herpesvirus 8 
(HHV-8) for example, replicates in activated, but not in 
quiescent, T lymphocytes (Frenkel et al., 1990). Alterna- 
tively, the activation of NF-KB by HVS13 may play a role 
in the regulation of HVS gene expression. Expression of 
HIV-l has been shown to be dependent on tandem KB 
binding sites in its long terminal repeats (Nabel and Balti- 
more, 1987). Cytomegalovirus (CM/), another member of 
the herpesvirus family, contains NF-ICB recognition sites 
in its genome and is transcriptionally stimulated by NF-KB 
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(Sambucetti et al., 1989; Kowalik et al., 1993). Another 
possible function of HVS13 might be to induce a subset 
of cytokines that may control the host immune responses. 
For example, the viral homolog of IL-10 encoded by EBV 
inhibits IFNy synthesis and accessory cell functions of 
macrophages and thus, inhibits virus-induced T and natu- 
ral killer cell activation (Hsu et al., 1990; Moore et al., 
1993). 
Given that different cell types, including fibroblasts, T, 
and B lineage cells express IL-17R, this ligand-receptor 
system may play an important role in the interaction of 
these cell types with one another during an immune re- 
sponse. The fact that IL-1 7 (mCTLA8) regulates T cell pro- 
liferation and is expressed by activated T cells raises the 
interesting possibility of a role for IL-17 (mCTLA8) as an 
autocrine factor. The finding that a soluble form of the 
IL-17R inhibits T cell proliferation induced by polyclonal 
mitogens and anti-TCR MAb suggests that endogenously 
produced IL-17 (mCTLA8) and its receptor may be in- 
volved in early T cell activation and growth. 
ExPerimental Procedures 
Cell Lines snd Virus 
The murine thymoma cell line EL4 was grown in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 5% fetal bovine serum 
(FBS), 100 pglml pyruvate, 50 U/ml penicillin, 50 pglml streptomycin, 
5 x lo* M P-mercaptoethanol. OMK and fibroblast 3T3 cell mono- 
layers were maintained in DMEM containing 10% FBS, supplemented 
with 10 mM nonessential amino acids, 50 U/ml +enicillin, 50 &ml 
streptomycin. HVS was propagated on OMK cell monolayers. 
Plasmld Constructton and ExPressIon 
Asolubletype II HVS13.Fc wasconstructed in the mammalian expres- 
sion vebtor pDC406 (McMahan et al., 1991). The CH2 and CH3 do- 
mains of human IgGl, which correspond to amino acids 242-470 
(Crowe et al., 1992) and a (IGly,]Serb repeat that serves as a flexible 
linker domain were inserted downstrea! of the murine IL-7 leader 
sequence (amino acids l-22). This construct was subcloned into 
pDC406 vector and the resulting plasmid digested with BspEl and 
Notl: Oligonucleotide primers were used in PCR reactions to amplify 
an HVSIB-specific DNA fragment encoding amino acids 19-151 (full- 
length excluding signal peptide) using HVS DNA as a template. The 
primers added a BspEl site at the 5’end and a Notl site at the 3’ end 
of the fragment. The PCR product was cut and cloned into the pDC406 
carrying the human IgGl.Fc region and flexible linker sequence. An 
unmodified form of HVS13 was constructed by cloning the complete 
coding region of HVS13 into a mammalian expression vector pDC409, 
a derivative of the vector pDC406. The inserts were sequenced in their 
entirety. To%onstruct a mCTLAB.Fc, two primers were designed based 
on the published sequence (Rouvier et al., 1993) to amplify a DNA 
fragment that would encode amino acids 20-150. RNA was prepared 
from EL4 cells, reverse transcribed with oligo dT primers, and IL-17 
(mCTlA8) cDNA was amplified. The PCR fragment was cut and a 
type II mCTlAB.Fc was constructed in a similar way as described for 
HVS13.Fc. A soluble unmodified form of IL-17 (mCTLA8) was con- 
structed by cloning IL-1 7 (mCTlA8) residues 20-l 50 into a vector with 
an IL-7 leader sequence. A control Fc was constructed in a similar 
way by fusing amino acids 19-258 of a vaccinia virus ORF ~7.5 to 
the Fc portion of the human IgGl. A soluble form of IL-17R.Fc fusion 
protein (type I Fc) was constructed in the mammalian expression vector 
pDC409 by fusing the extracellular domain of IL-17R (residue l-322) 
to the Fc domain of human IgG1. 
DEAE transfections were performed in CVl/EBNA cells as de 
scribed (McMahan et al., 1991). The supernatants from transfected 
cells were pooled and filtered using a 0.45 pm filter and stored at 
-70°C before use. Fc fusion purifications were performed as described 
(Fanslow et al., 1992). Protein concentration was determined by an 
ELISA specific for the constant domain of human IgGl and purity 
confirmed by SDS-PAGE followed by silver stain of the gel. The puri- 
fied proteins for biological assays were screened for low endotoxin 
levels (<I pg/ml at their final concentration) using the Limulus ame 
bocyte lysate assay (Whittaker M. A. Bioproducts. Walkersville, Mary- 
land). 
Antfsera and MAb 
A mouse HVS13 antiserum was prepared by immunizing BALB/c mice 
with HVS13.Fc fusion protein. Immune sera were tested by ELISA for 
reactivity to the fusion protein and for their abilityto immunoprecipitate 
the non-Fc form of HVSI 3 protein. Spleen cells were fused with murine 
myeloma 8.653 in the presence of selection medium and supernatants 
tested for binding to HVS13 by ELISA. Hybridomas that produced 
antibodies positive for binding to HVS13.Fc. but not an irrelevant Fc 
protein, were cloned by limited dilution methods and further tested 
by immunoprecipitation. To generate an anti-IL-17R serum, rats were 
immunized with soluble IL-17R.Fc fusion protein. 
I8otoplc Labsllng and lmmunopreclpltatlon 
CVl/EBNA cells were transfected as described above. Cells were Ia- 
beled 48 hr post-DNA transfection with 100 CCi of L-pS]methionine 
(Amenham, Arlington Heights, Illinois) for 3 hr at 37OC. Alternatively, 
HVS-infected cells were labeled with 300 pCi of L-(s6S]methionine for 
24 hr. The supernatants and cell lysates were harvested and clarified 
at 14,000 x g for 30 min. For immunoprecipitation, supernatants or 
cell lysates were incubated with polyclonal antiserum or preimmune 
serum followed by the addition of protein A-sepharose beads. After 
extensive washing with phosphate-buffered saline buffer containing 
1% deoxycholate, 1% NP-40, and 0.1% SDS, immunoprecipitates 
were analyzed on 8%-16% SDS-PAGE. 
Flow CytomeWlc Analysis 
Cells (1 x 1 q were preincubated on ice for 30 min in 100 )rl of FACS 
buffer (phosphate-buffered saline, 1% FBS, and 0.1% NaNa) con- 
taining 2% normal goat serum and 2% normal rabbit serum to block 
nonspecific binding. HVS13.Fc, mCTLA&Fc, or control Fc protein(100 
~I)wasaddedat5rg/mlandincubatedonicefor30min.A~erwashing, 
the cells were stained with phycoerythrinconjugated anti-human IgG 
(Fc specific) (Becton Dickinson and Company, Mountain View, Califor- 
nia) in 100 ~1 of FACS buffer. Cells were then washed and a minimum 
of 5,000 cells were analyzed using a FACScan (Becton Dickinson). 
Screening of the Murlne EL4 cDNA fixfwssfon Llbrary 
A murine EL4 cDNA library was constructed and screened as pre 
viouslydescribed (McMahan et al., 1991; Armitage et al., 1992; Good- 
win et al., 1993). In brief, CVlIEBNA cell monolayers on chamber 
slides were transfected with plasmid DNAs derived from pooled trans- 
formants. Cell monolayers were incubated 2 days after transfection 
with 1 pg/ml of HVS13.Fc. then washed, and incubated with ‘“l-labeled 
goat anti-human IgG (New England Nuclear, Cambridge, Massachu- 
setts). After extensive washing, cells were fixed, dipped in photo 
graphic emulsion, and then developed. Positive pools of cDNAs were 
identified and subdivided into smaller cDNA clones until singlepositive 
clones were isolated. 
Northern Blot Analysis 
Filters containing poly(A)+ RNA (2 rg per lane) from various tissues 
were purchased from Clontech (Palo Alto, California). Polyadenylated 
RNA from various cells or cell lines was isolated, fractionated (2 pg 
per lane) on a 1% agaroae formaldehyde gel and blotted onto Hybond 
nylon membrane (Amenham). Filters were probed with an anti-sense 
RNA riboprobe corresponding to the coding region of IL-17R cDNA. 
Hybridization was performed at 63OC followed by three washings in 
0.2% x SSC, 0.1% SDS at 68OC. Blots were exposed for 8-48 hr at 
-70%. 
Cell Surfaoe Blotlnyfation and Immunopmcl~lon 
Cell surface protein labeling was performed as described (Meier et 
al., 1992). In brief, 3 x IO’of EL4cellsorCVllEBNA cells transfected 
with IL-17R cDNA in 6well plates were biotinylated and lysed. Lysates 
were precleared by centrifugation at 14.000 rpm for 15 min and precipi- 
tated with 5 rg/ml of HVS13.Fc or mCTLA8.Fc and run on 8%-16% 
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SDS-PAGE. The proteins were then blotted onto an enhanced chemi- 
luminescence (ECL) membrane (Amersham). The membrane was in- 
cubated with streptavidin-biotinylated horseradish peroxidase com- 
plex (Amersham) at 1:lOO dilution and developed using the ECL 
Western blot kit (Amersham)following the instructions of the manufac- 
turer. 
Chromosome Localization 
C3H/HeJ-g/d and Mus spretus (Spain) mice and ([C3H/HeJ-g/d x 
Mus spretus]Fl x CIHIHeJ-gld) interspecific backcross mice were 
bred and maintained as previously described (Seldin et al., 1988b). 
DNA isolated from mouseorgans was electrophoresed and transferred 
to Nytran membranes, hybridized at 85OC with radiolabeled IL-17R 
cDNA probes, and washed under stringent conditions, all as previously 
described (Watson and Seldin, 1994). Gene linkage was determined 
by segregation analysis (Green, 1981). Gene order was determined 
by analyzing all haplotypes and minimizing crossover frequency be- 
tween all genes that were determined to be within a linkage group. 
This method resulted in determination of the most likely gene order 
(Bishop, 1985). The mapping of the following reference loci in this 
interspecificcross have been previously described: Rafl and Cd4(Sel- 
din et al., 1988a; Pate1 et al., 1995). 
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